Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

MOUNJARO 2,5 MG SOLUCION INYECTABLE EN VIAL - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/MOUNJARO 2,5 MG SOLUCION INYECTABLE EN VIAL

Approved

STANDARD

MOUNJARO 2,5 MG SOLUCION INYECTABLE EN VIAL

Eli Lilly Nederland B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Feb 9, 2024
Approval ID: cb810f312ecb85e1
Company: Eli Lilly Nederland B.V.
Type: Standard

Approval Details

Approval Id: cb810f312ecb85e1
Drug Cima Aemps Name: MOUNJARO 2,5 MG SOLUCION INYECTABLE EN VIAL
Register Number: 1221685025
Holder Company Name: Eli Lilly Nederland B.V.
Marketing Company Name: Lilly S.A.
Holder Company Detail Path: /organization/eli-lilly-nederland-bv
Marketing Company Detail Path: /organization/lilly-sa
Authorization Date: 2024-02-09
Dosage Form: SOLUCIÓN INYECTABLE
Dose: 2,5 mg
Route Of Administration: VÍA SUBCUTÁNEA
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Eli Lilly Nederland B.V.
Company Detail Path: /organization/eli-lilly-nederland-bv

Company Information

Pharmaceutical Company Name: Eli Lilly Nederland BV
Country Name: Netherlands
Website: http://www.lilly.com/nl

Active Ingredients

TIRZEPATIDA

2,5 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 9, 2024

Approval ID

cb810f312ecb85e1

Type

Standard

Back to CIMA-AEMPS Approvals